It was found that when compared with the corresponding normal tissue, higher expressions of NTF2 were observed in the majority of the cancer types, including HNSCC (P < 0.001); bladder urothelial carcinoma (BLCA); breast invasive carcinoma (BRCA); cholangiocarcinoma (CHOL); colon adenocarcinoma (COAD); esophageal carcinoma (ESCA), and so on (Figures 1A, B). Here, NUTF2 is linked to bladder transitional cell carcinoma.